Catalyst

VRTX earnings

May 4, 2026

VRTX earnings — 2026-05-04

Reported the quarter ending 2026-03-31: revenue $2.99B, diluted EPS $4.02, net income $1.03B (SEC filing). Across the print the stock moved +0.1% (close before → first close after).

Backfilled from filed financials — a record of the print, not an analyst read.

10 events

DateTypeEvent

Apr 28 ScanBiotech Scan Apr 28 ScanHealthcare Scan Apr 26 UpdateBiotech Candidates Apr 26 ScanHealthcare Scan Apr 26 ScanBiotech Scan Apr 13 Scan2 — HEALTHCARE SCAN Apr 13 Scan1 — BIOTECH SCAN Apr 10 ScanBiotech Scan Apr 10 ScanHealthcare Scan May 29 UpdateBiotech Candidates

No direct external sources are attached to this read.